ImportRefusal LogoImportRefusal

Zhejiang Orient Gene Biotech

⚠️ Moderate Risk

FEI: 3008517993 • Huzhou, Zhejiang • CHINA

FEI

FEI Number

3008517993

📍

Location

Huzhou, Zhejiang

🇨🇳

Country

CHINA
🏢

Address

3787 East Yangguang Avenue Dipu Street, Anji, , Huzhou, Zhejiang, China

Moderate Risk

FDA Import Risk Assessment

49.4
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

17
Total Refusals
6
Unique Violations
1/18/2023
Latest Refusal
10/10/2012
Earliest Refusal

Score Breakdown

Violation Severity
64.5×40%
Refusal Volume
46.5×30%
Recency
40.0×20%
Frequency
16.5×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

50814×

NO 510(K)

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.

1183×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32802×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

2371×

NO PMA

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).

24801×

RXPERSONAL

The article appears to be a device which requires a prescription from your doctor.

3361×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

Refusal History

DateProductViolationsDivision
1/18/2023
83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
508NO 510(K)
Division of West Coast Imports (DWCI)
3/23/2022
83QLWCOVID-19 TEST HOME COLLECTION KIT DEVICES
508NO 510(K)
Division of Southeast Imports (DSEI)
3/11/2022
83QLWCOVID-19 TEST HOME COLLECTION KIT DEVICES
508NO 510(K)
Division of Southeast Imports (DSEI)
3/7/2022
83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
508NO 510(K)
Division of Northern Border Imports (DNBI)
3/7/2022
83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
508NO 510(K)
Division of Southeast Imports (DSEI)
2/15/2022
83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
508NO 510(K)
Division of Southeast Imports (DSEI)
1/27/2022
83QLWCOVID-19 TEST HOME COLLECTION KIT DEVICES
508NO 510(K)
Division of Southeast Imports (DSEI)
1/14/2022
83QLWCOVID-19 TEST HOME COLLECTION KIT DEVICES
508NO 510(K)
Division of Southeast Imports (DSEI)
1/6/2022
75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER
3280FRNMFGREG
Division of Southeast Imports (DSEI)
9/3/2021
83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
237NO PMA
Division of Southeast Imports (DSEI)
5/12/2021
83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
118NOT LISTED
3280FRNMFGREG
508NO 510(K)
Division of Southeast Imports (DSEI)
9/5/2020
83QJRREAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
508NO 510(K)
Division of West Coast Imports (DWCI)
7/22/2020
83QJRREAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
2480RXPERSONAL
508NO 510(K)
Division of Southeast Imports (DSEI)
5/19/2020
83OTGNON-SARS CORONAVIRUS MULTIPLEX NUCLEIC ACID ASSAY
508NO 510(K)
Division of Southeast Imports (DSEI)
5/5/2020
83QJRREAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
336INCONSPICU
508NO 510(K)
Division of Southeast Imports (DSEI)
4/25/2019
57YH99BIOLOGICAL IN-VIVO AND IN-VITRO DIAGNOSTICS, N.E.C.
118NOT LISTED
Division of Southeast Imports (DSEI)
10/10/2012
91NGLTEST, OPIATES, OVER THE COUNTER
118NOT LISTED
508NO 510(K)
Seattle District Office (SEA-DO)

Frequently Asked Questions

What is Zhejiang Orient Gene Biotech's FDA import refusal history?

Zhejiang Orient Gene Biotech (FEI: 3008517993) has 17 FDA import refusal record(s) in our database, spanning from 10/10/2012 to 1/18/2023.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Zhejiang Orient Gene Biotech's FEI number is 3008517993.

What types of violations has Zhejiang Orient Gene Biotech received?

Zhejiang Orient Gene Biotech has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Zhejiang Orient Gene Biotech come from?

All FDA import refusal data for Zhejiang Orient Gene Biotech is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.